Skip to content

Non-Hodgkin's Lymphoma

Font Size

Adult Non-Hodgkin Lymphoma Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options for Non-Hodgkin Lymphoma

continued...

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with adult Burkitt lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Waldenström Macroglobulinemia

Treatment of Waldenström macroglobulinemia may include the following:

  • Watchful waiting.
  • Plasmapheresis and chemotherapy.
  • Combinations of chemotherapy using one or more anticancer drugs and targeted therapy with a monoclonal antibody or a proteasome inhibitor.
  • Biologic therapy with interferon.
  • A clinical trial of stem cell transplant.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with Waldenström macroglobulinemia. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Recurrent Adult Non-Hodgkin Lymphoma

Indolent, Recurrent Adult Non-Hodgkin Lymphoma

Treatment of indolent, recurrent adult non-Hodgkin lymphoma may include the following:

  • Chemotherapy with one or more drugs.
  • Radiation therapy.
  • Radiation therapy and/or chemotherapy as palliative therapy to relieve symptoms and improve quality of life.
  • Monoclonal antibody therapy.
  • A clinical trial of radiolabeled monoclonal antibody therapy.
  • A clinical trial of monoclonal antibody therapy as palliative therapy to relieve symptoms and improve quality of life.
  • A clinical trial of autologous or allogeneic stem cell transplant.

Treatment of indolent lymphoma that comes back as aggressive lymphoma may include the following:

  • A clinical trial of autologous or allogeneic stem cell transplant.
  • A clinical trial of combination chemotherapy followed by radiation therapy or stem cell transplant and radiation therapy.
  • A clinical trial of monoclonal antibody therapy.
  • A clinical trial of radiolabeled monoclonal antibody therapy.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with indolent, recurrent adult non-Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

1|2|3|4
Next Article:

Today on WebMD

stem cells
What are they and why do we need them?
Lung cancer xray
See it in pictures, plus read the facts.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Do you know the symptoms?
 
Vitamin D
SLIDESHOW
New Treatments For Non-Hodgkins Lymphoma
FEATURE
 
Lifestyle Tips for Depression Slideshow
SLIDESHOW
Pets Improve Your Health
SLIDESHOW
 

WebMD Special Sections